In 2023, many popular peptides were placed in Category 2 substances for which the FDA has identified significant safety concerns effectively restricting their compounding
Patients with a history of chronic pancreatitis, pancreatic cancer, or other significant pancreatic disorders may not be suitable candidates for this therapy
It is not offered for human or veterinary use, and no protocol, administration or outcome guidance is provided
It combines the stabilizing benefits of glycine with the energy-supporting effects of B12
For patients experiencing weight regain, the timing of intervention depends on several factors including the degree of regain, presence of obesity-related comorbidities, and documentation of adherence to behavioral recommendations
Travel and time zone changes Traveling across time zones disrupts your circadian rhythm, and your skin's rhythm along with it